LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 130 filers reported holding LOXO ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 2.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,434,000 | -23.2% | 67,353 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $12,283,000 | -23.8% | 71,903 | -22.6% | 0.00% | 0.0% |
| Q2 2018 | $16,126,000 | +413.2% | 92,956 | +241.4% | 0.00% | – |
| Q1 2018 | $3,142,000 | +188.5% | 27,227 | +110.3% | 0.00% | – |
| Q4 2017 | $1,089,000 | -14.2% | 12,944 | -6.0% | 0.00% | – |
| Q3 2017 | $1,269,000 | +231.3% | 13,769 | +187.5% | 0.00% | – |
| Q2 2017 | $383,000 | +11.3% | 4,789 | -41.4% | 0.00% | – |
| Q1 2017 | $344,000 | +244.0% | 8,176 | +162.6% | 0.00% | – |
| Q4 2016 | $100,000 | +35.1% | 3,113 | +9.5% | 0.00% | – |
| Q3 2016 | $74,000 | +17.5% | 2,842 | +4.1% | 0.00% | – |
| Q2 2016 | $63,000 | +14.5% | 2,729 | +35.5% | 0.00% | – |
| Q1 2016 | $55,000 | +3.8% | 2,014 | +6.9% | 0.00% | – |
| Q4 2015 | $53,000 | +51.4% | 1,884 | -5.9% | 0.00% | – |
| Q3 2015 | $35,000 | -7.9% | 2,003 | -4.0% | 0.00% | – |
| Q2 2015 | $38,000 | -44.1% | 2,087 | -61.8% | 0.00% | – |
| Q1 2015 | $68,000 | – | 5,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
| DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
| Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
| Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
| AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
| Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
| Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
| Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |